Suven Pharma is primarily engaged in the development and manufacturing of NCE-based KSMs, bulk drugs/ intermediates for human health as well as specialty chemicals under contract research and ...

Goldamn Sachs has initiated coverage of two Indian pharmaceuticals, Suven Pharma and Piramal Pharma, rating the stocks as a 'Buy' for its first rating. The brokerage has cited the reasons behind ...

Favoured for their rugged looks and raised driving position, large SUVs and 4x4s are very popular in the UK. The best large SUVs are also practical, with comfortable and spacious interiors. And – on ...

Suven Life Sciences Limited (Formerly known as Suven Pharmaceuticals Ltd) was incorporated in March 1989. The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limited ...

HSBC Small Cap Fund - Direct (G) 264.51 22,98,085 1.82 HSBC Small Cap Fund - Direct (IDCW) 264.51 22,98,085 1.82 DSP ELSS Tax Saver Fund (G) 247.69 21,51,917 1.53 DSP ELSS Tax Saver Fund (IDCW) 247.69 ...

Brokerage firm Goldman Sachs on Tuesday, April 8, initiated coverage on two pharma stocks — Suven Pharma Ltd. and Piramal Pharma Ltd. The brokerage initiated coverage with a "buy" rating on Suven ...

Suven Life Sciences Ltd., incorporated in the year 1989, is a Mid Cap company (having a market cap of Rs 2,655.27 Crore) operating in Pharmaceuticals sector. Suven Life Sciences Ltd. key ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...